UnitedHealth Stock (UNH) Jumps 8% after CMS Surprise. Let’s See Who Owns It Ahead of Earnings

FomoAnxiety · 2026-04-07T04:51:59+00:00

UnitedHealth shares surged nearly 8% after CMS confirmed a 2.48% Medicare Advantage payment increase for 2027, alleviating medical cost concerns. Despite projected earnings decline, ownership data shows strong institutional interest, and Wall Street rates the stock as a Strong Buy.

FomoAnxiety

2026-04-07 04:51:59

Abstract generation in progress

UnitedHealth stock UNH +1.48% ▲ jumped nearly 8% in after-hours trading on Monday after the Centers for Medicare & Medicaid Services (CMS) finalized its 2027 Medicare Advantage (MA) payment update. The agency confirmed a 2.48% increase in payments to private insurers, an improvement from the near-flat rate proposed in January. The higher update helps ease concerns about rising medical costs and supports a better profit outlook.

Easter Sale - 70% Off TipRanks

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Meanwhile, the company is set to report its first-quarter fiscal 2026 results before the market opens on Tuesday, April 21. Wall Street expects earnings per share (EPS) to decline 8% year over year to $6.65, while revenue is projected at $109.58 billion, roughly in line with the same period last year. With this in focus, let’s take a closer look at who owns UNH stock.

Now, according to TipRanks’ Ownership Tool, public companies and individual investors own 49.17% of UnitedHealth. They are followed by mutual funds, ETFs, other institutional investors, and insiders at 26.66%, 22.37%, 1.62%, and 0.18%, respectively.

Digging Deeper into UNH’s Ownership Structure

Looking closely at the top shareholders, Vanguard owns the highest stake in UnitedHealth at 8.72%, followed by Vanguard Index Funds with a 6.69% holding.

Among the top ETF holders, the Vanguard Total Stock Market ETF VTI +0.45% ▲ holds a 3.16% stake in UNH, while the Vanguard S&P 500 ETF VOO +0.44% ▲ owns 2.57%.

Moving to mutual funds, Vanguard Index Funds holds about 6.69% of UnitedHealth. Meanwhile, Fidelity Concord Street Trust owns 1.71% of the company.

Is UNH a Good Buy?

Turning to Wall Street, UNH stock has a Strong Buy consensus rating based on 18 Buys, four Holds, and zero Sells assigned in the last three months. At $368.15, the average UnitedHealth stock price target implies a 30.85% upside potential.

Disclaimer & DisclosureReport an Issue

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.